Temperature preconditioning of isolated rat hearts – a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore
Open Access
- 6 June 2007
- journal article
- research article
- Published by Wiley in The Journal of Physiology
- Vol. 581 (3) , 1147-1161
- https://doi.org/10.1113/jphysiol.2007.130369
Abstract
We investigate whether temperature preconditioning (TP), induced by short‐term hypothermic perfusion and rewarming, may protect hearts against ischaemic/reperfusion injury like ischaemic preconditioning (IP). Isolated rat hearts were perfused for 40 min, followed by 25 min global ischaemia and 60 min reperfusion (37°C). During pre‐ischaemia, IP hearts underwent three cycles of 2 min global ischaemia and 3 min reperfusion at 37°C, whereas TP hearts received three cycles of 2 min hypothermic perfusion (26°C) interspersed by 3 min normothermic perfusion. Other hearts received a single 6 min hypothermic perfusion (SHP) before ischaemia. Both IP and TP protocols increased levels of high energy phosphates in the pre‐ischaemic heart. During reperfusion, TP improved haemodynamic recovery, decreased arrhythmias and reduced necrotic damage (lactate dehydrogenase release) more than IP or SHP. Measurements of tissue NAD+ levels and calcium‐induced swelling of mitochondria isolated at 3 min reperfusion were consistent with greater inhibition of the mitochondrial permeability transition at reperfusion by TP than IP; this correlated with decreased protein carbonylation, a surrogate marker for oxidative stress. TP increased protein kinase Cɛ (PKCɛ) translocation to the particulate fraction and pretreatment with chelerythrine (PKC inhibitor) blocked the protective effect of TP. TP also increased phosphorylation of AMP‐activated protein kinase (AMPK) after 5 min index ischaemia, but not before ischaemia. Compound C (AMPK inhibitor) partially blocked cardioprotection by TP, suggesting that both PKC and AMPK may mediate the effects of TP. The presence of N‐(2‐mercaptopropionyl) glycine during TP also abolished cardioprotection, indicating an involvement of free radicals in the signalling mechanism.Keywords
This publication has 74 references indexed in Scilit:
- AMP-Activated Protein Kinase: A Key Stress Signaling Pathway in the HeartTrends in Cardiovascular Medicine, 2005
- AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolismCell Metabolism, 2005
- Chelerythrine is a potent and specific inhibitor of protein kinase CPublished by Elsevier ,2004
- Apomorphine prevents myocardial ischemia/reperfusion-induced oxidative stress in the rat heartFree Radical Biology & Medicine, 2004
- Preconditioning protects by inhibiting the mitochondrial permeability transitionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Pyruvate prevents cardiac dysfunction and AMP-activated protein kinase activation by hydrogen peroxide in isolated rat heartsCanadian Journal of Physiology and Pharmacology, 2004
- Protein kinase activation and myocardial ischemia/reperfusion injuryCardiovascular Research, 2004
- Matrix volume measurements challenge the existence of diazoxide/glibencamide-sensitive KATP channels in rat mitochondriaThe Journal of Physiology, 2003
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Effect of Ischemic Preconditioning and PKC Activation on Acidification During Ischemia in Rat HeartJournal of Molecular and Cellular Cardiology, 1996